About G-Rish Pharma
G-Rish Pharma is a company based in Navi Mumbai (India) founded in 2012. It operates as a B2B. The company has 1 employees. G-Rish Pharma operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Navi Mumbai, India
- Employees 1
- SectorsHealthcare
- Website g-rishpharma.com
- Legal Name G-Rish Pharma Private Limited
- Date of Incorporation 13 Jul, 2022
- Jurisdiction Navi Mumbai, Maharashtra, India
- Annual Revenue₹31.80 Cr
FY 2024
- Net Profit₹58.6 Lakh
FY 2024 · 2% margin
- EBITDA₹1.25 Cr
FY 2024 · 4% margin
- Employee Count1
Associated legal entities of G-Rish Pharma
G-Rish Pharma operates through G-Rish Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| G-Rish Pharma Private Limited CIN U24230MH2022PTC386662 | Active | 13 Jul 2022 | Navi Mumbai, Maharashtra | ₹31.8 Cr | – | 3 | View details |
Board of directors of G-Rish Pharma Private Limited (G-Rish Pharma)
G-Rish Pharma Private Limited is the primary company behind G-Rish Pharma. The board of G-Rish Pharma Private Limited currently have 3 directors; the longest-serving is Vaibhav Saraf, appointed in 2022.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vaibhav Saraf DIN 07283629 | Managing Director | 13 Jul 2022 | 4 yrs 3 mo | G-Rish Pharma Private Limited |
| Gaurav Ajay Saraf DIN 06719469 | Director | 13 Jul 2022 | 4 yrs 3 mo | G-Rish Pharma Private Limited |
| Gunja Gaurav Saraf DIN 09672512 | Director | 13 Jul 2022 | 4 yrs 3 mo | G-Rish Pharma Private Limited |
Financials of G-Rish Pharma
Figures of G-Rish Pharma Private Limited, the primary company behind G-Rish Pharma, for FY 2024. Revenue was ₹31.80 Cr. Net profit was ₹58.6 Lakh (2% margin). EBITDA was ₹1.25 Cr (4% margin).
- ₹31.80 CrRevenue · FY 2024
- ₹58.6 LakhNet profit · 2% margin
- ₹1.25 CrEBITDA · 4% margin
- ₹1 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of G-Rish Pharma Private Limited are on its company page.
Detailed financial statements for G-Rish Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of G-Rish Pharma
G-Rish Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| provepharm.com | 1998 | Marseille, France | $145.93M | – | APIs and drug products are developed and valorized in pharmaceuticals. | |
| biostar-pharm.com | 2002 | Beijing, China | $135.23M | – | APIs, intermediates, and biochemical reagents are developed and manufactured. | |
| sequent.in | 2002 | Bengaluru, India | – | – | APIs are developed and manufactured for therapeutic areas. | |
| sterlingpharmasolutions.com | 2016 | Dudley, United Kingdom | – | 560 | Contract development, manufacturing, and analytical services for APIs are offered. | |
| snapdragonchemistry.com | 2014 | Cambridge, United States | – | 43 | Drug discovery and development service provider | |
| jubilantpharma.com | 1978 | Noida, India | – | – | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | |
| hikal.com | 1988 | Mumbai, India | – | 355 | APIs and intermediates are produced via custom synthesis and research. |
Detailed competitors of G-Rish Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to G-Rish Pharma
10 companies that operate in the same segment as G-Rish Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about G-Rish Pharma
G-Rish Pharma was founded in 2012.
G-Rish Pharma is headquartered in Navi Mumbai, India. It is registered at Navi Mumbai, Maharashtra, India.
G-Rish Pharma has 1 employees.
The primary company behind G-Rish Pharma, G-Rish Pharma Private Limited, reported revenue of ₹31.80 Cr for FY 2024.
G-Rish Pharma, based in Navi Mumbai, focuses on providing healthcare solutions, producing pharmaceutical products, supply and export, and apis and excipients. G-Rish Pharma supplies and exports APIs, excipients, and intermediates to the healthcare industry. The company prioritizes operational excellence, innovation, and customer-centric approaches for success.
G-Rish Pharma's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
G-Rish Pharma operates through G-Rish Pharma Private Limited.
The legal entities of G-Rish Pharma currently have 3 directors, including Vaibhav Saraf, Gaurav Ajay Saraf, Gunja Gaurav Saraf.